LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Dasatinib
0.1
24.73 17.25 1166 1290 0.9037 0.9677
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
24.73 17.25 1404 1290 1.0882 1.0273
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
26.70 17.25 11 1466 0.0075 -0.0678
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
26.70 17.25 1374 1466 0.9368 0.9797
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
26.70 17.25 1291 1466 0.8802 0.9606
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
26.70 17.25 1486 1466 1.0131 1.0041
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
28.67 17.25 16 1653 0.0097 -0.0114
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
28.67 17.25 1518 1653 0.9183 0.9743
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
28.67 17.25 1373 1653 0.8305 0.9444
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
28.67 17.25 1585 1653 0.9588 0.9873
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
30.64 17.25 21 1887 0.0111 0.0295
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
30.64 17.25 1636 1887 0.8668 0.9582
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
30.64 17.25 1531 1887 0.8112 0.9392
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
30.64 17.25 1727 1887 0.9150 0.9739
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
32.61 17.25 19 2136 0.0089 0.0140
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
32.61 17.25 1728 2136 0.8089 0.9399
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
32.61 17.25 1684 2136 0.7883 0.9327
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
32.61 17.25 1890 2136 0.8847 0.9651
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
34.57 17.25 8 2523 0.0032 -0.1013
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
34.57 17.25 1854 2523 0.7348 0.9161
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
34.57 17.25 1858 2523 0.7364 0.9167
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
34.57 17.25 2012 2523 0.7974 0.9380
MN20160310_N02
N04
MCF 10A-H2B-mCherry Dasatinib
0.1
36.54 17.25 4 2679 0.0015 -0.1819
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
36.54 17.25 2024 2679 0.7553 0.9244
MN20160310_N02
K22
MCF 10A-H2B-mCherry Dasatinib
0.1
36.54 17.25 1994 2679 0.7441 0.9204
MN20160310_N02
N04